Lyra Coronavirus
by Diagnostic Hybrids, Inc. 2 variants
Ref M124Model Lyra
Lyra Coronavirus (M124) is a SARS-CoV-2 nucleic acid IVD (EU IVDD general IVD; FDA product code QJR, Reagents, 2019-novel coronavirus nucleic acid) made by Diagnostic Hybrids, Inc., registered in EUDAMED on 22 Oct 2026 (Basic UDI-DI B-30014613339144) and listed in FDA GUDID since 17 Feb 2021 (UDI-DI 30014613339144), active as of 7 Nov 2026.
Active
CE IVDD
Valid until
No date given
FDA recalls
Not checked
Documents
None, self-declared
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD EUDAMED | NumberB-30014613339144 30014613339144 | Date22 Oct 2026 | StatusActive |
| United States | GUDID listing GUDID | Number30014613339144 | Date17 Feb 2021 | StatusListed |
Official records
- EUDAMED public site B-30014613339144
- AccessGUDID record 30014613339144
From the FDA record
- Device description
- SARS-CoV-2 Direct Assay
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI B-30014613339144 registered 22 Oct 2026 Active
- FDA GUDID UDI-DI 30014613339144 listed 17 Feb 2021 Listed
Certificates
No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.
Timeline
- Listed FDA GUDID 30014613339144
- Registered EUDAMED B-30014613339144
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Lyra Direct SARS-CoV-2 EUDAMEDLyra GUDID
- Generic name
- SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device name
- Direct SARS-CoV-2
- Model / Ref / Catalog
- Lyra, M124, Coronavirus
- Primary DI / UDI-DI
- 30014613339144
- Basic UDI-DI
- B-30014613339144
- FDA product code
- QJR
- EMDN code
- W0105041106 Coronavirus - na reagents
- GMDN term
- SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class IVD General EUDAMEDN GUDID
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Italy
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Model / reference | Lyra M124 | Coronavirus |
| Device class | Class IVD General | N |
Similar devices in this category
Other devices filed under CORONAVIRUS - NA REAGENTS.
- Helix Elite™ Molecular Standards: Inactivated Standard by MICROBIOLOGICS, INC.
- 2019-Novel Coronavirus, Influenza A and B virus nucleic acid test kit (Fluorescent Probe-based real-time PCR assay) R208T050B0C2 by Jiangsu Mole Bioscience Co., LTD.
- Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit (PCR-Fluorescence Probing) ZC-HX-201-3 by Shanghai BioGerm Medical Technology Co., Ltd.
- RevoDx SARS-CoV-2 qPCR Kit v2.2 IP202008-500 by İDİL BİOTECH ARAŞTIRMA SAN. VE TİC. LTD. ŞTİ.
- QC Sets and Panels: Helix Elite™ by MICROBIOLOGICS, INC.
- ARMS-PCR Detection Kit for 2019-nCoV HV69-70del and N501Y mutation A9294YH by Beijing Applied Biological Technologies Co., Ltd.
- Multiple Real-Time PCR Kit for Detection of 2019-nCoV A7793YF-50T by Beijing Applied Biological Technologies Co., Ltd.
- RevoDx Direct SARS-CoV-2 qPCR Kit on 96/384-well plate (Extraction-free) IP202221-96 by İDİL BİOTECH ARAŞTIRMA SAN. VE TİC. LTD. ŞTİ.
- Aptima® ASY-17190 by Hologic
- BD Respiratory Viral Panel for BD MAX™ System 445373 by Becton, Dickinson and Company